Daniel G. Wilson
CFO & Principal Financial OfficerMr. Daniel G. Wilson, also known as Dan, served as an Executive Vice President of Corporate Strategy at iRhythm Holdings, Inc. (formerly known as iRhythm Technologies, Inc.) since September 2022 until April 2023 and served as its Executive Vice President of Corporate Development & Investor Relations since April 2023 and was its Executive Vice President of Strategy, Corporate Development since June 2019 until September 2022 and serves as its Chief Financial Officer and Principal Financial Officer from August 31, 2024. Previously, he served as Director and Head of Business Development at Penumbra, Inc., a global healthcare company focused on innovative therapies. Prior to Penumbra, he held various positions at J.P. Morgan (between August 2006 and May 2016), over his tenure, as Executive Director in the Healthcare Investment Banking group focused on digital health, medical technology and emerging healthcare companies. He held various positions in Piper Jaffray?s Healthcare Investment Banking group from August 2004 to August 2006. He started his career at KPMG as an Audit Associate from September 2003 to August 2004. Mr. Wilson has a B.S. in Business Administration from California Polytechnic State University at San Luis Obispo.
Positions
- Company NameiRhythm Holdings, Inc.Stock CodeIRTCPositionCFO & Principal Financial OfficerColleagues
- QSQuentin S. BlackfordPresident, CEO & Director
- AYAbhijit Y. TalwalkarIndependent Chairman
- MPMinang P. TurakhiaChief Medical & Scientific Officer and Executive VP of Advanced Technologies
- PMPatrick Michael MurphyChief Business & Legal Officer
- CMChad M. PattersonChief Commercial and Product Officer
- BGBruce George BodakenIndependent Director
- KLKaren L. LingIndependent Director
- KKKaren K. McGinnisIndependent Director
